Document is current
Any future updates will be listed below
-
Authors
Krassuski, Timo
Bäumer, Nicole
Niland, Stephan
Grunert, Katharina
Wittmann, Lisa
Eble, Johannes A.
Lenz, Georg
Berdel, Wolfgang E.
Bäumer, Sebastian
-
Funding
Funding for this research was provided by:
Universitätsklinikum Münster
- License Information
-
More Information
Article History
Received: 13 May 2026
Accepted: 7 August 2026
First Online: 18 August 2026
Declarations
Competing interests: NB, SB, WEB and GL have filed patent applications on electrostatic nanocarrier technology. GL received research grants not related to this manuscript from Abbvie, Gilead, MorphoSys, F. Hoffmann-La Roche Ltd. and Sobi. GL received honoraria from ADC Therapeutics, AbbVie, AstraZeneca, BeiGene, BMS, Genmab, Gilead, GSK, Hexal/Sandoz, Immagene/Flindr, Incyte, Lilly, Miltenyi, MorphoSys, MSD, Novartis, PentixaPharm, Pierre Fabre, F. Hoffmann-La Roche Ltd, and Sobi. All other authors disclose no conflict of interest.
